Contact: John Sterling, 914-740-2196, email@example.com
Genetic Engineering & Biotechnology News Unveils “Biotech Boulevard”
New Rochelle, NY, August 6, 2012—Genetic Engineering & Biotechnology News (GEN) has launched a unique microsite called Biotech Boulevard. Biotech Boulevard features entrepreneurial biotechnology firms that are already making their mark on the global bioindustry. Many of these promising young companies are engaged in the discovery of novel therapeutics; others are developing new tools and technologies to support biotech activities ranging from early-stage R&D to biomanufacturing.
Each Biotech Boulevard listing includes a company name, website, logo, and short description of the company’s field of focus. “Biotech Boulevard allows our website visitors to discover, invest, and collaborate,” said John Sterling, Editor-in-Chief, GEN. “Company listings will be updated regularly.”
“Biotech Boulevard is another GEN innovation that enables business growth in biotech,” added Mary Ann Liebert, GEN publisher and president and CEO of Mary Ann Liebert, Inc. “And we are the best at that.”
If you would like your company to be considered for possible inclusion in Biotech Boulevard, please email your company name and website to firstname.lastname@example.org
Genetic Engineering & Biotechnology News, which is published 21 times a year by Mary Ann Liebert, Inc., is the most widely read biotechnology news magazine worldwide. It includes articles on Drug Discovery, Bioprocessing, OMICS, Biobusiness, and Translational Medicine.